John Oyler is CEO at BeiGene, Ltd. (BGNE). They have made 83 open-market trades across 2 companies since 2017, most recently 2026-08-12.
CIK 0001042047
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 83 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| BGNE | 10,154,040 | $1.9B |
| ONC | 14,102 | $5.2M |
| Total | $1.9B |
Shares reported on the most recent Form 4, priced at the 2026-08-12 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 33% | 33% | 11% |
| Avg Move | +8.1% | +11.4% | +40.5% |
| Scored | 9 | 9 | 9 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ONC | SELL · 10b5-1 | 2026-08-10 | 2026-08-12 | $359.12 | $86.5M | +3.4% | -3.6% | — |
| ONC | SELL · 10b5-1 | 2026-07-20 | 2026-07-22 | $315.28 | $34.6M | -1.8% | +17.3% | — |
| ONC | SELL · 10b5-1 | 2026-07-17 | 2026-07-17 | $312.00 | $20.2M | +3.3% | +14.5% | +18.2% |
| ONC | SELL · 10b5-1 | 2026-07-15 | 2026-07-17 | $315.56 | $89.4M | +3.3% | +14.5% | +18.2% |
| ONC | SELL · 10b5-1 | 2026-07-14 | 2026-07-14 | $305.95 | $44.6M | +5.1% | +14.8% | +13.2% |
| ONC | SELL · 10b5-1 | 2026-07-10 | 2026-07-14 | $303.18 | $18.3M | +5.1% | +14.8% | +13.2% |
| ONC | SELL | 2026-06-23 | 2026-06-25 | $273.78 | $934K | +9.5% | +18.2% | +32.5% |
| ONC | SELL | 2026-06-16 | 2026-06-18 | $265.55 | $981K | +8.8% | +16.2% | +30.5% |
| ONC | SELL | 2026-06-11 | 2026-06-15 | $257.24 | $501K | +4.9% | +16.8% | +32.7% |
| ONC | SELL | 2026-06-08 | 2026-06-10 | $270.56 | $1.3M | +7.0% | +15.6% | +36.1% |
| ONC | SELL · 10b5-1 | 2025-12-15 | 2025-12-17 | $306.63 | $59.9M | -0.4% | +10.6% | -6.0% |
| ONC | SELL · 10b5-1 | 2025-09-16 | 2025-09-18 | $325.70 | $18.0M | +1.7% | -4.9% | -8.6% |
| ONC | SELL · 10b5-1 | 2025-07-09 | 2025-07-11 | $253.38 | $14.1M | +17.9% | +15.9% | +34.3% |
| ONC | SELL | 2025-06-23 | 2025-06-25 | $261.59 | $1.6M | -7.0% | +10.9% | +25.2% |
| ONC | SELL | 2025-06-16 | 2025-06-18 | $261.82 | $1.7M | +0.3% | +20.5% | +33.8% |
| ONC | SELL | 2025-06-06 | 2025-06-10 | $253.11 | $1.5M | -1.0% | -2.5% | +33.3% |
| BGNE | SELL | 2025-03-10 | 2025-03-12 | $243.09 | $17.2M | N/A | N/A | N/A |
| BGNE | SELL | 2025-03-07 | 2025-03-07 | $249.02 | $24.6M | N/A | N/A | N/A |
| BGNE | SELL | 2025-03-06 | 2025-03-07 | $259.17 | $18.6M | N/A | N/A | N/A |
| BGNE | SELL | 2025-03-03 | 2025-03-05 | $244.20 | $48.2M | N/A | N/A | N/A |
| BGNE | SELL · 10b5-1 | 2024-10-08 | 2024-10-10 | $232.21 | $7.5M | -5.8% | -12.5% | N/A |
| BGNE | SELL | 2024-06-24 | 2024-06-26 | $159.54 | $826K | +1.6% | +14.2% | +47.1% |
| BGNE | SELL | 2024-06-17 | 2024-06-20 | $159.46 | $361K | -6.2% | +4.9% | +28.6% |
| BGNE | SELL · 10b5-1 | 2024-04-09 | 2024-04-11 | $149.50 | $14.9M | -4.1% | +11.8% | +0.7% |
| BGNE | SELL | 2024-03-12 | 2024-03-14 | $167.28 | $16.6M | -10.5% | -19.4% | -2.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.